After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Mind Medicine Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Mind Medicine Inc is $275.69M. A total of 2.96 million shares were traded on the day, compared to an average of 1.71M shares.
In the most recent transaction, Barrow Robert sold 13,237 shares of MNMD for 3.63 per share on Dec 26 ’23. After the transaction, the Chief Executive Officer now owns 596,721 company shares. In a previous transaction on Dec 26 ’23, Karlin Dan sold 6,774 shares at 3.63 per share. MNMD shares that Chief Medical Officer owns now total 365,030.
Among the insiders who sold shares, Greenway Schond L. disposed of 5,652 shares on Dec 26 ’23 at a per-share price of $3.63. This resulted in the Chief Financial Officer holding 216,617 shares of MNMD after the transaction. In another insider transaction, Barrow Robert sold 13,499 shares at $3.58 per share on Sep 25 ’23. Company shares held by the Chief Executive Officer now total 611,729.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, MNMD has a high of $11.10 and a low of $2.41.
As of this writing, MNMD has an earnings estimate of -$0.42 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.28 per share and a lower estimate of -$0.56. The company reported an EPS of -$0.45 in the last quarter, which was 32.80% higher than expectations of -$0.67.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. MNMD’s latest balance sheet shows that the firm has $133.54M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $10.41M in liabilities at the time. Its Book Value Per Share was $1.90, while its Total Shareholder’s Equity was $151.66M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MNMD is Buy with a score of 4.86.
